Civik Thomas has filed 7 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 690131 shares of Pyxis Oncology, Inc. ($PYXS) on February 03, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | Pyxis Oncology, Inc. | $PYXS | Civik Thomas | Interim CEO | A | Stock Option (Right to Buy) | 690131 | $0.00 | 690,131.0000 | 62,557,386 | 9999.99% | 1.10% |
| Jan. 28, 2026 | Repare Therapeutics Inc. | $RPTX | Civik Thomas | Not found | D | Common Shares | 7500 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.02% |
| March 31, 2025 | Pyxis Oncology, Inc. | $PYXS | Civik Thomas | Not found | A | Stock Option (Right to Buy) | 36979 | $0.98 | 36,979.0000 | 58,445,765 | 9999.99% | 0.06% |
| June 17, 2024 | Repare Therapeutics Inc. | $RPTX | Civik Thomas | Not found | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 42,093,293 | 9999.99% | 0.06% |
| March 26, 2024 | Pyxis Oncology, Inc. | $PYXS | Civik Thomas | Not found | A | Stock Option (Right to Buy) | 44024 | $3.83 | 44,024.0000 | 39,904,603 | 9999.99% | 0.11% |
| June 8, 2023 | Repare Therapeutics Inc. | $RPTX | Civik Thomas | Director | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Civik Thomas | Director | A | Common Stock | 139355 | $0.00 | 221,886.0000 | 0 | 168.85% | 0.00% |